Literature DB >> 15852007

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.

Senad Divanovic1, Aurelien Trompette, Sowsan F Atabani, Rajat Madan, Douglas T Golenbock, Alberto Visintin, Robert W Finberg, Alexander Tarakhovsky, Stefanie N Vogel, Yasmine Belkaid, Evelyn A Kurt-Jones, Christopher L Karp.   

Abstract

Activation of Toll-like receptor (TLR) signaling by microbial signatures is critical to the induction of immune responses. Such responses demand tight regulation. RP105 is a TLR homolog thought to be mostly B cell specific, lacking a signaling domain. We report here that RP105 expression was wide, directly mirroring that of TLR4 on antigen-presenting cells. Moreover, RP105 was a specific inhibitor of TLR4 signaling in HEK 293 cells, a function conferred by its extracellular domain. Notably, RP105 and its helper molecule, MD-1, interacted directly with the TLR4 signaling complex, inhibiting its ability to bind microbial ligand. Finally, RP105 regulated TLR4 signaling in dendritic cells as well as endotoxin responses in vivo. Thus, our results identify RP105 as a physiological negative regulator of TLR4 responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852007      PMCID: PMC2144914          DOI: 10.1038/ni1198

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

Review 1.  Endotoxin tolerance-current concepts in historical perspective.

Authors:  Alan S Cross
Journal:  J Endotoxin Res       Date:  2002

2.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 3.  Innate immune sensing and its roots: the story of endotoxin.

Authors:  Bruce Beutler; Ernst Th Rietschel
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

4.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

Review 5.  Inflammatory bowel disease: new insights into pathogenesis and treatment.

Authors:  S Ardizzone; G Bianchi Porro
Journal:  J Intern Med       Date:  2002-12       Impact factor: 8.989

Review 6.  The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation.

Authors:  Clifton O Bingham
Journal:  J Rheumatol Suppl       Date:  2002-09

7.  Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils.

Authors:  Evelyn A Kurt-Jones; Leisa Mandell; Constance Whitney; Alison Padgett; Kerri Gosselin; Peter E Newburger; Robert W Finberg
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Of mice and men: species variations of Toll-like receptor expression.

Authors:  Michael Rehli
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

9.  Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

Authors:  Eicke Latz; Alberto Visintin; Egil Lien; Kate A Fitzgerald; Brian G Monks; Evelyn A Kurt-Jones; Douglas T Golenbock; Terje Espevik
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

10.  Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.

Authors:  Kimberly Burns; Sophie Janssens; Brian Brissoni; Natalia Olivos; Rudi Beyaert; Jürg Tschopp
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  145 in total

1.  Crystal structure of soluble MD-1 and its interaction with lipid IVa.

Authors:  Sung-il Yoon; Minsun Hong; Gye Won Han; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.

Authors:  Gary D Ainge; William John Martin; Benjamin J Compton; Colin M Hayman; David S Larsen; Sung-Il Yoon; Ian A Wilson; Jacquie L Harper; Gavin F Painter
Journal:  J Med Chem       Date:  2011-10-05       Impact factor: 7.446

3.  S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Jun Li; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2011-01-25       Impact factor: 3.362

4.  Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous.

Authors:  Jessica L Allen; Leah M Flick; Senad Divanovic; Shaun W Jackson; Richard Bram; David J Rawlings; Fred D Finkelman; Christopher L Karp
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

5.  Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.

Authors:  Pearl Gray; Kathrin S Michelsen; Cherilyn M Sirois; Emily Lowe; Kenichi Shimada; Timothy R Crother; Shuang Chen; Constantinos Brikos; Yonca Bulut; Eicke Latz; David Underhill; Moshe Arditi
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

Review 6.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

7.  TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses.

Authors:  D M Appledorn; S Patial; S Godbehere; N Parameswaran; A Amalfitano
Journal:  J Innate Immun       Date:  2009-03-04       Impact factor: 7.349

Review 8.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

Review 9.  Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.

Authors:  Hailin Zhao; Jessica Santiváñez Perez; Kaizhi Lu; Andrew J T George; Daqing Ma
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-12

10.  Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model.

Authors:  Ze Zheng; Xiaohua Xu; Xuebao Zhang; Aixia Wang; Chunbin Zhang; Maik Hüttemann; Lawrence I Grossman; Lung Chi Chen; Sanjay Rajagopalan; Qinghua Sun; Kezhong Zhang
Journal:  J Hepatol       Date:  2012-08-15       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.